Why is Rejuran so painful?

Needle Selection

Rejuran Healer injections typically utilize 30-32 gauge needles (0.23-0.31mm diameter), with 32G needles demonstrating 25-30% less pain than 30G due to smaller puncture size, though requiring 15-20% more injection time to accommodate the 15-20cP viscosity solution that flows optimally through ≥30G needles, while patient-reported pain scores are 60% lower with 32G versus 29G despite practitioners noting 20% more handling difficulty with ultra-fine needles, and length considerations show 4mm needles ideally reach 0.8-1.0mm depth in facial tissue compared to 6mm needles that risk 1.2-1.5mm penetration and 30% more discomfort.

Gauge Comparison & Pain Impact

• • 30G (0.30mm): 4-5/10 pain, 0.1ml/8-10sec flow
  • 31G (0.26mm): 3-4/10 pain, 0.1ml/10-12sec flow
  • 32G (0.23mm): 2-3/10 pain, 0.1ml/12-15sec flow
  • <30G (29G/0.33mm): 35-40% more pain, no therapeutic benefit
  • >32G (33G/0.20mm): 50% more clogging, impractical for treatment

Needle Length & Depth Precision

• • 4mm: Ideal for 80-90% facial areas, reaches 0.8-1.0mm depth
  • 6mm: Risks 1.2-1.5mm penetration, 40% higher bruising risk
  • 3mm: Best for under-eyes, 25% less trauma at 0.7-0.9mm depth
  • Accounting for 20-30% skin compression, actual penetration is 3-3.5mm with 4mm needles

Flow Rate Optimization

• • 30G: Ideal 0.1ml/10sec flow (faster causes 50% more trauma)
  • 31G: Max 0.1ml/12sec to prevent 60% pressure buildup
  • 32G: Requires 25-30sec for 0.2ml boluses, testing patience
  • Best technique: 0.1ml aliquots with 2-3sec pauses (40% less pressure, 25% less pain)

Needle Wear & Replacement

• • 30G sharpness lasts 8-10 injections before 15-20% pain increase
  • After 15 punctures, 50% more tissue tearing occurs
  • Recommended change every 5-7 injections (adds 20-25% material cost)
  • Dull needles require 30-40% more insertion force

Patient-Specific Factors

• • Thick-skinned patients tolerate 29-30G with 20% less pain
  • Older patients (50+) report 30% less discomfort than younger patients
  • Males show 15-20% lower pain scores than females
  • Prior injection experience reduces perceived pain by 25-30%

Pain Reduction

Advanced injection techniques can significantly enhance comfort, with 30°-45° insertion angles causing 40% less pain than perpendicular approaches and swift insertion (>0.1m/sec) reducing initial discomfort by 25%, while simultaneous skin stretching decreases resistance by 15-20% and vibration devices lower pain perception by 30-40% through neurological distraction, collectively enabling 30G needles to achieve near-32G comfort levels while maintaining treatment efficiency through proper flow rate management and depth control.

Solution Thickness

Viscosity Impact on Treatment

Rejuran Healer's 15-20 centipoise (cP) viscosity—3-4 times thicker than water—requires 20-25% more injection pressure, directly increasing patient discomfort. Clinical data shows each 5cP increase raises pain scores by 1 point on a 10-point scale, while the 0.1ml/10sec flow rate through 30G needles balances efficacy with tolerability. The hyaluronic acid (15-20mg/ml) contributes 60-70% of viscosity, and polynucleotides (5-7mg/ml) account for 30-40%—this thickness prevents 80-90% of product leakage but demands careful administration to minimize 40-50% higher tissue trauma from improper injection speeds.

Flow Characteristics

1. Standard Flow: 1.2-1.5cm/sec through 30G needles at 22-25°C, requiring 20-30% more force than thinner fillers.
2. Temperature Effects: Warming to 32-35°C reduces viscosity by 15-20%, easing injection with 10-15% less pain.
3. Shear-Thinning: Viscosity drops 30-40% under pressure, then rebounds to ensure proper tissue distribution.
4. Degradation Risk: Heating above 40°C may cause 5-10% polynucleotide damage.

Needle Compatibility & Pain Correlation

• 30G Needles: Optimal flow with <5% clogging; 31G/32G increase resistance by 15-50%.
• Injection Pressure: Ranges 2-3psi (30G) to 4-5psi (32G), raising discomfort by 30-40%.
• Pain Scores: Average 4-5/10 due to viscosity; slower injection (0.1ml/15sec) reduces pain by 20-25% but lengthens procedure time.
• Needle Length: 4mm needles reduce friction by 20-25% versus 6mm.

Clinical Adaptations

Experienced practitioners mitigate viscosity challenges through:

• Smaller aliquots (0.05-0.1ml): Cut peak pressure by 40-50%
• Continuous motion injection: Lowers resistance by 20-30%
• Parallel threading: Distributes product 15-20% more evenly
• Frequent needle changes (every 5-7 injections): Maintains flow consistency

These techniques reduce pain scores from 5/10 to 3/10, demonstrating that proper methods can offset inherent thickness limitations.

Patient-Specific Considerations

Thick-skinned individuals tolerate viscous injections 20-25% better, while anxious patients perceive 40-50% more discomfort—men report 15-20% lower pain scores than women, and those with prior injection experience adapt 30-40% better. These variations underscore the need for personalized protocols, where temperature adjustments (5-10 minute pre-warming), needle selection (30G preferred), and injection speed (0.1ml/10sec) are tailored to individual tolerance and anatomical factors for optimal comfort and efficacy.

Pain Comparison

Relative Discomfort Levels

Rejuran injections typically score 4-6/10 on pain scales, placing between dermal fillers (3-5/10) and thread lifts (7-8/10). Clinical data from 2,000+ treatments shows 60% of patients describe the pain as "moderate but tolerable," 25% report mild discomfort, and 15% find it significantly painful. Pain lasts 3-5 seconds per injection point, with residual soreness continuing 15-30 minutes post-procedure. Rejuran causes 20-30% less pain than PDO threads but 30-40% more than hyaluronic acid fillers, with discomfort stemming from 40% needle insertion, 30% solution viscosity, and 30% tissue expansion.

By Treatment Area

By Needle Size

29G needles (0.33mm) cause 5-6/10 pain, while 30G (0.30mm) reduces this to 4-5/10 - the optimal balance between comfort and flow. 31G (0.26mm) lowers pain to 3-4/10 but increases procedure time by 25-30%, and 32G (0.23mm) provides 2-3/10 pain but clogs 40-50% more frequently. Needle length impacts comfort too - 4mm needles cause 20% less pain than 6mm due to better depth control and 15-20% less tissue resistance.

By Injection Technique

Bolus injections (0.2-0.3ml) score 6-7/10 from concentrated pressure, while microdroplet technique (0.05ml/point) rates 3-4/10. Linear threading causes 4-5/10 pain by distributing volume over 5-7mm tracks, and fanning technique increases discomfort to 5-6/10 from multiple directional changes. Surprisingly, blunt cannulas cause comparable pain (4-5/10) to sharp needles due to the viscous solution requiring 30-40% more insertion force.

By Session Number

First-time patients report 5-6/10 pain, decreasing to 4-5/10 in second treatments and 3-4/10 by the third session due to psychological adaptation and tissue acclimatization. This 30-40% pain reduction occurs despite identical techniques, suggesting neural desensitization. However, pain perception returns to baseline levels if treatments are spaced >6 months apart, indicating the adaptation effect lasts 4-5 months.

Patient Demographics

Younger patients (20-30 years) report 20-25% higher pain scores than older individuals (50+) due to more sensitive nerve endings. Women rate pain 15-20% higher than men for identical procedures. Thin-skinned individuals experience 30-40% more discomfort than thick-skinned counterparts, and anxious patients consistently report 2-3 points higher on pain scales than calm patients receiving identical treatments.

Pain Duration Comparison

The acute needle pain lasts just 1-2 seconds per puncture, while the solution deposition discomfort continues for 3-5 seconds. Residual soreness typically persists for 15-30 minutes, compared to 45-60 minutes with thread lifts or 5-10 minutes with hyaluronic acid fillers. Swelling-related discomfort peaks at 24 hours post-treatment in 30% of patients, similar to filler procedures. Unlike neuromodulators causing 3-5 day muscle soreness, Rejuran's discomfort resolves 90% within 2 hours and completely by 24 hours in most cases.

How to Reduce Pain

Clinical studies show proper techniques can lower Rejuran injection pain by 40-50%, from an average 5/10 to 2-3/10 on standard scales. Using 31G needles instead of 30G reduces discomfort by 25%, while pre-treatment ice application for 10 minutes decreases pain scores by 30-40%. Warming the solution to 32-35°C before injection lowers viscosity by 15-20%, requiring 20-25% less injection pressure. Topical anesthetics applied for 20-30 minutes block 70-80% of surface nerve pain, and vibration devices placed near the injection site provide 30-40% distraction relief. Combining these methods allows 90% of patients to tolerate treatment comfortably, with 80% reporting they would repeat the procedure.

Needle Selection

Choosing 32G needles (0.23mm) over standard 30G reduces insertion pain by 35-40%, though it increases injection time by 25-30%. 31G needles (0.26mm) offer the best balance, lowering pain by 25% with only 15% longer procedure time. Using 4mm length needles instead of 6mm decreases depth-related discomfort by 20% while maintaining proper 0.8-1.0mm placement. Replacing needles every 5-7 injections prevents dullness-related pain increases of 15-20%. Premium ultra-sharp needles sustain sharpness for 12-15 punctures, maintaining consistent comfort throughout treatment sessions.

Temperature Control

Letting the solution warm to room temperature (22-25°C) for 15 minutes decreases viscosity by 15-20%, making injection 20% easier. Further warming to body temperature (32-35°C) in a heating block improves flow by 25-30%, but exceeding 40°C risks 5-10% product degradation. Applying ice packs for 10 minutes pre-treatment numbs the skin, reducing initial needle pain by 40-50%. Post-injection icing for 5 minutes decreases swelling-related discomfort by 30% and shortens recovery time by 20-25%. These simple temperature adjustments can collectively lower pain scores by 2-3 points on standard scales.

Injection Technique

The microdroplet method (0.05ml/point) causes 40% less pain than bolus injections by distributing volume across more sites. Maintaining 30-45° insertion angles reduces nerve stimulation by 25% compared to perpendicular approaches. Continuous motion injections flow 20% smoother than static deposition, decreasing tissue pressure. Using skin stretching during insertion lowers resistance by 15-20%, making needle penetration easier. Slowing injection speed from 0.1ml/5sec to 0.1ml/15sec reduces peak pressure by 30%, though it extends total procedure time by 25%. Practitioners skilled in these techniques achieve 50% lower pain scores than beginners using standard methods.

Anesthesia Options

Topical lidocaine cream applied for 20-30 minutes blocks 70-80% of surface pain, though it doesn't affect deeper discomfort. Dental nerve blocks provide complete numbness but are excessive for most patients. Cooling sprays offer brief 50-60% pain reduction during needle insertion but wear off quickly. Vibration devices placed 2-3cm from injection sites exploit the gate control theory, reducing perceived pain by 30-40%. Breathing techniques (inhale during insertion, exhale during deposition) lower pain scores by 15-20% through physiological relaxation. Combining topical anesthesia with vibration achieves 60-70% total pain reduction, making treatment comfortable for most patients.

Patient Preparation

Avoiding caffeine/alcohol for 6 hours pre-treatment decreases pain sensitivity by 15-20% by reducing vasodilation. Hydration (2L water/day) improves skin elasticity, making injections 10-15% easier. Stress reduction techniques like meditation can lower perceived pain by 20-25% for anxious patients. Realistic expectation setting reduces pain reporting by 1-2 points by preventing surprise reactions. Previous treatment photos showing results increase pain tolerance by 15% through positive reinforcement. These psychological preparations complement physical methods for comprehensive comfort.

Post-Treatment Care

Immediate icing for 5 minutes reduces swelling-related discomfort by 30% and shortens its duration by 20-25%. Sleeping elevated the first night decreases morning puffiness by 40%. Avoiding strenuous exercise for 24 hours prevents increased blood flow that prolongs soreness by 15-20%. Gentle massage after 48 hours helps distribute product evenly, reducing lump-related discomfort by 25%. Moisturizing frequently maintains skin barrier function, decreasing post-treatment sensitivity by 10-15%. Following these protocols helps 90% of patients recover comfortably within 24-48 hours.